What's new in atopic eczema? (Q37740142)

22 August 2017

1 reference

title

What's new in atopic eczema? (English)

1 reference

22 August 2017

Sabine Gisela Plötz

1

1 reference

22 August 2017

Johannes Ring

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Expert Opinion on Emerging Drugs

22 August 2017

published in

1 reference

22 August 2017

volume

15

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

249-267

1 reference

Atopic dermatitis: new insights and opportunities for therapeutic intervention

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Differences in skin‐prick and patch‐test reactivity are related to the heterogeneity of atopic eczema in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Why are allergies increasing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Childhood eczema: disease of the advantaged?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Hay fever, hygiene, and household size

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

The inverse association between tuberculin responses and atopic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Allergy, parasites, and the hygiene hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Age of entry to day nursery and allergy in later childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the Hygiene hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Cytokines and chemokines orchestrate atopic skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Skin barrier function, epidermal proliferation and differentiation in eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

The role of microorganisms in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Filaggrin mutations, atopic eczema, hay fever, and asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Secondary infections in patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Atopic dermatitis: a disease caused by innate immune defects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Corticosteroid-induced adverse events in adults: frequency, screening and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

The prevalence of corticosteroid allergy in two U.K. centres: prescribing implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Consensus statement on the safety profile of topical calcineurin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Pimecrolimus inhibits up-regulation of OX40 and synthesis of inflammatory cytokines upon secondary T cell activation by allogeneic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Phototherapy for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

The dark and the sunny sides of UVR-induced immunosuppression: photoimmunology revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Bacterial infections and atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Efficacy and functionality of silver-coated textiles in patients with atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Azathioprine for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

The genetics of atopic dermatitis: recent findings and future options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Gene polymorphism in Netherton and common atopic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

The therapeutic concept of "patient management" in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Mechanisms of immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Grass pollen immunotherapy decreases the number of mast cells in the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Immunomodulators for allergic respiratory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Are biologics safe in the treatment of atopic dermatitis? A review with a focus on immediate hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

IL-4/IL-13 signaling beyond JAK/STAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Treatment of patients with the hypereosinophilic syndrome with mepolizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

The role of IkappaB kinase 2, but not activation of NF-kappaB, in the release of CXCR3 ligands from IFN-gamma-stimulated human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

IL-31: a new link between T cells and pruritus in atopic skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Action of a silk fabric treated with AEGIS in children with atopic dermatitis: a 3-month trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

Increased activation of p38 MAPK in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728211003792518

10.1517/14728211003792518

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference